ACUTE GRAFT VERSUS HOST DISEASE
Clinical trials for ACUTE GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new ACUTE GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for ACUTE GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial for Kids' transplant complication halted after only 2 participants
Disease control TerminatedThis study aimed to test the safety and effectiveness of a new drug, itacitinib, when given with standard steroids to children who developed a serious complication called acute graft-versus-host disease after a stem cell transplant. The trial was designed for children and teens w…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New approach aims to tame dangerous transplant complication
Disease control TerminatedThis study tested a new combination of three drugs to treat a severe and dangerous complication called acute graft-versus-host disease (GVHD) that can happen after a stem cell or bone marrow transplant. The main goal was to find the lowest possible dose of steroids (corticosteroi…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC